McMorris v. Williamsport Hospital

597 F. Supp. 899, 1984 U.S. Dist. LEXIS 23343
CourtDistrict Court, M.D. Pennsylvania
DecidedSeptember 25, 1984
DocketCiv. 79-0438
StatusPublished
Cited by8 cases

This text of 597 F. Supp. 899 (McMorris v. Williamsport Hospital) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McMorris v. Williamsport Hospital, 597 F. Supp. 899, 1984 U.S. Dist. LEXIS 23343 (M.D. Pa. 1984).

Opinion

MEMORANDUM AND ORDER

NEALON, Chief Judge.

INTRODUCTION

The plaintiff commenced the above-captioned civil action on April 10, 1979, naming the Williamsport Hospital, its Board of Trustees, certain of its officers, Dr. Judith Gouldin and Dr. John Calce as defendants. In this suit, the plaintiff challenges, on various grounds, the hospital’s decision to replace him as director of its nuclear medicine department, to install Dr. Gouldin in his place and to accord to her the exclusive right to render official interpretations of nuclear scans and to use the rather sophisticated equipment needed to practice nuclear medicine. Some of the claims set forth in the original complaint have been eliminated by virtue of two Orders handed down by the court and a stipulation entered into by the parties. See Memorandum and Order dated October 15, 1982, Document 91 of the Record (granting defendants’ motion for summary judgment on plaintiff’s claim that the hospital breached his employment contract); Order dated July 26, 1982, Document 82 of the Record (dismissing plaintiff’s civil rights claims); Stipulation dated December 27, 1982, Document 127 of the Record (withdrawing all claims advanced under Section 2 of the Sherman Antitrust Act of 1890, 15 U.S.C. § 2 (1976)). The claims remaining for the court’s consideration are claims under Section 1 of the Sherman Act, 15 U.S.C. § 1 (1976), a breach of contract claim arising from the hospital’s by-laws and a tort claim based upon alleged interference with the plaintiff’s contract rights.

*901 Presently before the court is a motion for summary judgment filed by the defendants. Summary judgment is “a drastic remedy,” Tomalewski v. State Farm Life Ins. Co., 494 F.2d 882, 884 (3d Cir.1974); accord Ness v. Marshall, 660 F.2d 517, 519 (3d Cir.1981), and all doubts as to its propriety in a given case must be resolved against the moving party. See, e.g., United States ex rel. Jones v. Bundle, 453 F.2d 147, 150 (3d Cir.1971). As the Court of Appeals for the Third Circuit recently stated, “[s]ummary judgment may only be granted if, upon a review of the materials properly before the court, see Fed.R.Civ.P. 56(c), and viewing the evidence thus considered in a light most favorable to the non-moving party, the court is convinced that no genuine issue of material fact remains for trial and that the movant is entitled to judgment as a matter of law.” Lang v. New York Life Ins. Co., 721 F.2d 118, 119 (3d Cir.1983) (citing Scott v. Plante, 532 F.2d 939, 945 (3d Cir.1976)). In addressing the instant motion, the court also has considered the general rule that the summary judgment device “should be used sparingly in complex antitrust litigation.” Poller v. Columbia Broadcasting System, 368 U.S. 464, 473, 82 S.Ct. 486, 491, 7 L.Ed.2d 458 (1962); accord Cernuto, Inc. v. United Cabinet Corp., 595 F.2d 164, 165 & n. 2 (3d Cir.1979).

Nevertheless, these general rules should not be construed to preclude a court from entering summary judgment in an appropriate situation. Indeed, notwithstanding the caveat that summary judgment rarely should be entered in antitrust cases, Poller, 368 U.S. at 473, 82 S.Ct. at 491, a court is obligated to consider carefully a party’s Rule 56 motion under the particular facts of the given case and must stand ready, even in antitrust litigation, to enter judgment if appropriate. First National Bank v. Cities Service, 391 U.S. 253, 288-90, 88 S.Ct. 1575, 1592-93, 20 L.Ed.2d 569 (1968); Harold Friedman, Inc. v. Kroger Co., 581 F.2d 1068, 1080 (3d Cir.1978). “While we recognize the importance of preserving litigants’ rights to a trial on their claims, we are not prepared to extend those rights to the point of requiring that anyone who files an antitrust complaint setting forth a valid cause of action be entitled to a full-dress trial notwithstanding the absence of any significant probative evidence tending to support the complaint.” First National Bank, 391 U.S. at 290, 88 S.Ct. at 1593. Hence, after a movant has produced evidence demonstrating his entitlement to summary judgment, the party resisting the motion must produce affidavits or other admissible materials containing specific facts demonstrating the existence of a genuine triable issue. Tripoli Co. v. Wella Corp., 425 F.2d 932 (3d Cir.) (en banc), cert. denied, 400 U.S. 831, 91 S.Ct. 62, 27 L.Ed.2d 62 (1970); see also Fed.R.Civ.P. 56(e). A failure to do so will result in the entry of summary judgment. First National Bank, 391 U.S. at 289, 88 S.Ct. at 1592.

The parties have developed the record substantially, having engaged in extensive discovery during the course of this five-year-old case. The court has carefully reviewed the record in conjunction with the parties’ legal arguments and the standard of review discussed supra. For the reasons set forth below, the court will grant the defendants’ motion for summary judgment on all claims except for the plaintiff’s claim that the defendants have engaged in an unlawful tying arrangement violative of Section 1 of the Sherman Act.

FACTUAL BACKGROUND

In the practice of nuclear medicine, radioactive materials are used to diagnose and treat certain illnesses. Unknown before World War II, this medical specialty has become an important diagnostic and therapeutic tool. In therapeutic nuclear medicine, radioisotopes are used to destroy abnormal growths. In diagnostic nuclear medicine, two basic approaches are available. These are called the “in vivo” and the “in vitro” procedures.

When a doctor uses the “in vivo” approach, a radionuclide is introduced into the patient’s system through injection or in *902 gestión. Using various machines, the physician creates images of the patient or the affected body part at a key point in time following the introduction of the radioactive material. Because these radionuclides have unique properties, it is important for the practitioner to produce the image, or series of images, at the proper moment or moments during the procedure. The physician later interprets the image and arrives at a diagnosis.

In the “in vitro” diagnostic procedure, the physician does not introduce radioactive materials into the patient’s body. Rather, a specimen, usually a blood sample, is extracted from the patient.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kochert v. Greater Lafayette Health Services, Inc.
372 F. Supp. 2d 509 (N.D. Indiana, 2004)
Griffin v. Guadalupe Medical Center, Inc.
1997 NMCA 012 (New Mexico Court of Appeals, 1997)
In re Girard Medical Center
128 B.R. 938 (E.D. Pennsylvania, 1991)
Castelli v. Meadville Medical Center
702 F. Supp. 1201 (W.D. Pennsylvania, 1988)
Nurse Midwifery Associates v. Hibbett
689 F. Supp. 799 (M.D. Tennessee, 1988)
Ringtown Wilbert Vault Works v. Schuylkill Memorial Park, Inc.
650 F. Supp. 823 (E.D. Pennsylvania, 1986)
Weiss v. York Hospital
628 F. Supp. 1392 (M.D. Pennsylvania, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
597 F. Supp. 899, 1984 U.S. Dist. LEXIS 23343, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcmorris-v-williamsport-hospital-pamd-1984.